{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:23:39Z","timestamp":1773818619934,"version":"3.50.1"},"publisher-location":"Cham","reference-count":97,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319524429","type":"print"},{"value":"9783319524443","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.5"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/7854_2016_21","type":"book-chapter","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T12:55:36Z","timestamp":1476708936000},"page":"209-230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Neurotoxicology of Synthetic Cathinone Analogs"],"prefix":"10.1007","author":[{"given":"Mariana","family":"Angoa-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Anneken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald M.","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,18]]},"reference":[{"key":"21_CR1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1749-6632.2009.05141.x","volume":"1187","author":"BK Yamamoto","year":"2010","unstructured":"Yamamoto BK, Moszczynska A, Gudelsky GA (2010) Amphetamine toxicities: classical and emerging mechanisms. Ann N Y Acad Sci 1187:101\u2013121","journal-title":"Ann N Y Acad Sci"},{"key":"21_CR2","unstructured":"Moratalla R, Khairnar A, Simola N, Granado N, Garcia-Montes JR, Porceddu PF, Tizabi Y, Costa G, Morelli M (2015) Amphetamine-related drugs neurotoxicity in humans and in experimental animals: main mechanisms. Prog Neurobiol"},{"key":"21_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.104.070961","volume":"311","author":"DM Thomas","year":"2004","unstructured":"Thomas DM, Walker PD, Benjamins JA, Geddes TJ, Kuhn DM (2004) Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J Pharmacol Exp Ther 311:1\u20137","journal-title":"J Pharmacol Exp Ther"},{"key":"21_CR4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neulet.2004.06.065","volume":"367","author":"DM Thomas","year":"2004","unstructured":"Thomas DM, Dowgiert J, Geddes TJ, Francescutti-Verbeem D, Liu X, Kuhn DM (2004) Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines. Neurosci Lett 367:349\u2013354","journal-title":"Neurosci Lett"},{"key":"21_CR5","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1017\/S1461145714000145","volume":"17","author":"A Rubio-Araiz","year":"2014","unstructured":"Rubio-Araiz A, Perez-Hernandez M, Urrutia A, Porcu F, Borcel E, Gutierrez-Lopez MD, O\u2019Shea E, Colado MI (2014) 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier integrity through a mechanism involving P2X7 receptors. Int J Neuropsychopharmacol 17:1243\u20131255","journal-title":"Int J Neuropsychopharmacol"},{"key":"21_CR6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0196-0644(97)70351-2","volume":"29","author":"RW Rockhold","year":"1997","unstructured":"Rockhold RW, Carlton FB Jr, Corkern R, Derouen L, Bennett JG, Hume AS (1997) Methcathinone intoxication in the rat: abrogation by dextrorphan. Ann Emerg Med 29:383\u2013391","journal-title":"Ann Emerg Med"},{"key":"21_CR7","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1476-5381.2012.02236.x","volume":"168","author":"SE Shortall","year":"2013","unstructured":"Shortall SE, Green AR, Swift KM, Fone KC, King MV (2013) Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone-induced hypothermia. Br J Pharmacol 168:966\u2013977","journal-title":"Br J Pharmacol"},{"key":"21_CR8","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0022-3565(24)37162-9","volume":"283","author":"MP Gygi","year":"1997","unstructured":"Gygi MP, Fleckenstein AE, Gibb JW, Hanson GR (1997) Role of endogenous dopamine in the neurochemical deficits induced by methcathinone. J Pharmacol Exp Ther 283:1350\u20131355","journal-title":"J Pharmacol Exp Ther"},{"key":"21_CR9","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0022-3565(25)12381-1","volume":"276","author":"MP Gygi","year":"1996","unstructured":"Gygi MP, Gibb JW, Hanson GR (1996) Methcathinone: an initial study of its effects on monoaminergic systems. J Pharmacol Exp Ther 276:1066\u20131072","journal-title":"J Pharmacol Exp Ther"},{"key":"21_CR10","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.1523\/JNEUROSCI.18-20-08417.1998","volume":"18","author":"UD McCann","year":"1998","unstructured":"McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA (1998) Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J Neurosci 18:8417\u20138422","journal-title":"J Neurosci"},{"key":"21_CR11","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0022-3565(25)21220-4","volume":"279","author":"M Sparago","year":"1996","unstructured":"Sparago M, Wlos J, Yuan J, Hatzidimitriou G, Tolliver J, Dal Cason TA, Katz J, Ricaurte G (1996) Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): a new drug of abuse. J Pharmacol Exp Ther 279:1043\u20131052","journal-title":"J Pharmacol Exp Ther"},{"key":"21_CR12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1600-0773.2003.pto930504.x","volume":"93","author":"NV Cozzi","year":"2003","unstructured":"Cozzi NV, Foley KF (2003) Methcathinone is a substrate for the serotonin uptake transporter. Pharmacol Toxicol 93:219\u2013225","journal-title":"Pharmacol Toxicol"},{"key":"21_CR13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(99)00538-5","volume":"381","author":"NV Cozzi","year":"1999","unstructured":"Cozzi NV, Sievert MK, Shulgin AT, Jacob P 3rd, Ruoho AE (1999) Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines. Eur J Pharmacol 381:63\u201369","journal-title":"Eur J Pharmacol"},{"key":"21_CR14","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0022-3565(24)39008-1","volume":"295","author":"RR Metzger","year":"2000","unstructured":"Metzger RR, Haughey HM, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE (2000) Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia. J Pharmacol Exp Ther 295:1077\u20131085","journal-title":"J Pharmacol Exp Ther"},{"key":"21_CR15","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","volume":"168","author":"LD Simmler","year":"2013","unstructured":"Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J, Chaboz S, Hoener MC, Liechti ME (2013) Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 168:458\u2013470","journal-title":"Br J Pharmacol"},{"key":"21_CR16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0091-3057(87)90164-X","volume":"26","author":"RA Glennon","year":"1987","unstructured":"Glennon RA, Yousif M, Naiman N, Kalix P (1987) Methcathinone: a new and potent amphetamine-like agent. Pharmacol Biochem Behav 26:547\u2013551","journal-title":"Pharmacol Biochem Behav"},{"key":"21_CR17","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1471-4159.2011.07632.x","volume":"120","author":"M Angoa-Perez","year":"2012","unstructured":"Angoa-Perez M, Kane MJ, Francescutti DM, Sykes KE, Shah MM, Mohammed AM, Thomas DM, Kuhn DM (2012) Mephedrone, an abused psychoactive component of \u2018bath salts\u2019 and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum. J Neurochem 120:1097\u20131107","journal-title":"J Neurochem"},{"key":"21_CR18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.lfs.2013.07.015","volume":"97","author":"M Angoa-Perez","year":"2014","unstructured":"Angoa-Perez M, Kane MJ, Herrera-Mundo N, Francescutti DM, Kuhn DM (2014) Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus. Life Sci 97:31\u201336","journal-title":"Life Sci"},{"key":"21_CR19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/jnc.13048","volume":"133","author":"JH Anneken","year":"2015","unstructured":"Anneken JH, Angoa-Perez M, Kuhn DM (2015) 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: beta-ketoamphetamine modulation of neurotoxicity by the dopamine transporter. J Neurochem 133:211\u2013222","journal-title":"J Neurochem"},{"key":"21_CR20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.taap.2015.03.015","volume":"286","author":"R Lopez-Arnau","year":"2015","unstructured":"Lopez-Arnau R, Martinez-Clemente J, Rodrigo T, Pubill D, Camarasa J, Escubedo E (2015) Neuronal changes and oxidative stress in adolescent rats after repeated exposure to mephedrone. Toxicol Appl Pharmacol 286:27\u201335","journal-title":"Toxicol Appl Pharmacol"},{"key":"21_CR21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1177\/0269881113490325","volume":"27","author":"CP Motbey","year":"2013","unstructured":"Motbey CP, Clemens KJ, Apetz N, Winstock AR, Ramsey J, Li KM, Wyatt N, Callaghan PD, Bowen MT, Cornish JL, McGregor IS (2013) High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine. J Psychopharmacol 27:823\u2013836","journal-title":"J Psychopharmacol"},{"key":"21_CR22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045473","volume":"7","author":"CP Motbey","year":"2012","unstructured":"Motbey CP, Karanges E, Li KM, Wilkinson S, Winstock AR, Ramsay J, Hicks C, Kendig MD, Wyatt N, Callaghan PD, McGregor IS (2012) Mephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletion. PLoS One 7, e45473","journal-title":"PLoS One"},{"key":"21_CR23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/jnc.12114","volume":"125","author":"M Angoa-Perez","year":"2013","unstructured":"Angoa-Perez M, Kane MJ, Briggs DI, Francescutti DM, Sykes CE, Shah MM, Thomas DM, Kuhn DM (2013) Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA. J Neurochem 125:102\u2013110","journal-title":"J Neurochem"},{"key":"21_CR24","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/npp.2011.304","volume":"37","author":"MH Baumann","year":"2012","unstructured":"Baumann MH, Ayestas MA Jr, Partilla JS, Sink JR, Shulgin AT, Daley PF, Brandt SD, Rothman RB, Ruoho AE, Cozzi NV (2012) The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37:1192\u20131203","journal-title":"Neuropsychopharmacology"},{"key":"21_CR25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099002","volume":"9","author":"J Martinez-Clemente","year":"2014","unstructured":"Martinez-Clemente J, Lopez-Arnau R, Abad S, Pubill D, Escubedo E, Camarasa J (2014) Dose and time-dependent selective neurotoxicity induced by mephedrone in mice. PLoS One 9, e99002","journal-title":"PLoS One"},{"key":"21_CR26","doi-asserted-by":"crossref","unstructured":"Shortall SE, Spicer CH, Ebling FJ, Green AR, Fone KC, King MV (2015) Contribution of serotonin and dopamine to changes in core body temperature and locomotor activity in rats following repeated administration of mephedrone. Addict Biol","DOI":"10.1111\/adb.12283"},{"key":"21_CR27","volume":"7","author":"MJ Wright Jr","year":"2012","unstructured":"Wright MJ Jr, Angrish D, Aarde SM, Barlow DJ, Buczynski MW, Creehan KM, Vandewater SA, Parsons LH, Houseknecht KL, Dickerson TJ, Taffe MA (2012) Effect of ambient temperature on the thermoregulatory and locomotor stimulant effects of 4-methylmethcathinone in Wistar and Sprague-Dawley rats. PLoS One 7, e44652","journal-title":"PLoS One"},{"key":"21_CR28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pbb.2012.10.006","volume":"103","author":"B den Hollander","year":"2013","unstructured":"den Hollander B, Rozov S, Linden AM, Uusi-Oukari M, Ojanpera I, Korpi ER (2013) Long-term cognitive and neurochemical effects of \u201cbath salt\u201d designer drugs methylone and mephedrone. Pharmacol Biochem Behav 103:501\u2013509","journal-title":"Pharmacol Biochem Behav"},{"key":"21_CR29","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.euroneuro.2012.09.005","volume":"23","author":"SE Shortall","year":"2013","unstructured":"Shortall SE, Macerola AE, Swaby RT, Jayson R, Korsah C, Pillidge KE, Wigmore PM, Ebling FJ, Richard Green A, Fone KC, King MV (2013) Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat. Eur Neuropsychopharmacol 23:1085\u20131095","journal-title":"Eur Neuropsychopharmacol"},{"key":"21_CR30","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1111\/bph.13266","volume":"172","author":"A Ciudad-Roberts","year":"2015","unstructured":"Ciudad-Roberts A, Camarasa J, Ciudad CJ, Pubill D, Escubedo E (2015) Alcohol enhances the psychostimulant and conditioning effects of mephedrone in adolescent mice; postulation of unique roles of D3 receptors and BDNF in place preference acquisition. Br J Pharmacol 172:4970\u20134984","journal-title":"Br J Pharmacol"},{"key":"21_CR31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/toxsci\/kfu108","volume":"141","author":"B den Hollander","year":"2014","unstructured":"den Hollander B, Sundstrom M, Pelander A, Ojanpera I, Mervaala E, Korpi ER, Kankuri E (2014) Keto amphetamine toxicity-focus on the redox reactivity of the cathinone designer drug mephedrone. Toxicol Sci 141:120\u2013131","journal-title":"Toxicol Sci"},{"key":"21_CR32","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/bph.12061","volume":"168","author":"KN Cameron","year":"2013","unstructured":"Cameron KN, Kolanos R, Solis E Jr, Glennon RA, De Felice LJ (2013) Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter. Br J Pharmacol 168:1750\u20131757","journal-title":"Br J Pharmacol"},{"key":"21_CR33","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.bcp.2013.04.004","volume":"85","author":"AJ Eshleman","year":"2013","unstructured":"Eshleman AJ, Wolfrum KM, Hatfield MG, Johnson RA, Murphy KV, Janowsky A (2013) Substituted methcathinones differ in transporter and receptor interactions. Biochem Pharmacol 85:1803\u20131815","journal-title":"Biochem Pharmacol"},{"key":"21_CR34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1476-5381.2012.01998.x","volume":"167","author":"R Lopez-Arnau","year":"2012","unstructured":"Lopez-Arnau R, Martinez-Clemente J, Pubill D, Escubedo E, Camarasa J (2012) Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone. Br J Pharmacol 167:407\u2013420","journal-title":"Br J Pharmacol"},{"key":"21_CR35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.euroneuro.2011.07.009","volume":"22","author":"J Martinez-Clemente","year":"2012","unstructured":"Martinez-Clemente J, Escubedo E, Pubill D, Camarasa J (2012) Interaction of mephedrone with dopamine and serotonin targets in rats. Eur Neuropsychopharmacol 22:231\u2013236","journal-title":"Eur Neuropsychopharmacol"},{"key":"21_CR36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.euroneuro.2014.12.012","volume":"25","author":"A Rickli","year":"2015","unstructured":"Rickli A, Hoener MC, Liechti ME (2015) Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones. Eur Neuropsychopharmacol 25:365\u2013376","journal-title":"Eur Neuropsychopharmacol"},{"key":"21_CR37","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s11064-015-1566-5","volume":"40","author":"B Budzynska","year":"2015","unstructured":"Budzynska B, Boguszewska-Czubara A, Kruk-Slomka M, Kurzepa J, Biala G (2015) Mephedrone and nicotine: oxidative stress and behavioral interactions in animal models. Neurochem Res 40:1083\u20131093","journal-title":"Neurochem Res"},{"key":"21_CR38","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1007\/s00213-014-3493-6","volume":"231","author":"R Lopez-Arnau","year":"2014","unstructured":"Lopez-Arnau R, Martinez-Clemente J, Abad S, Pubill D, Camarasa J, Escubedo E (2014) Repeated doses of methylone, a new drug of abuse, induce changes in serotonin and dopamine systems in the mouse. Psychopharmacology (Berl) 231:3119\u20133129","journal-title":"Psychopharmacology (Berl)"},{"key":"21_CR39","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1177\/0269881114548439","volume":"28","author":"R Lopez-Arnau","year":"2014","unstructured":"Lopez-Arnau R, Martinez-Clemente J, Pubill D, Escubedo E, Camarasa J (2014) Serotonergic impairment and memory deficits in adolescent rats after binge exposure of methylone. J Psychopharmacol 28:1053\u20131063","journal-title":"J Psychopharmacol"},{"key":"21_CR40","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/npp.2014.191","volume":"40","author":"EA Kiyatkin","year":"2015","unstructured":"Kiyatkin EA, Kim AH, Wakabayashi KT, Baumann MH, Shaham Y (2015) Effects of social interaction and warm ambient temperature on brain hyperthermia induced by the designer drugs methylone and MDPV. Neuropsychopharmacology 40:436\u2013445","journal-title":"Neuropsychopharmacology"},{"key":"21_CR41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/FBP.0000000000000135","volume":"26","author":"YS Piao","year":"2015","unstructured":"Piao YS, Hall FS, Moriya Y, Ito M, Ohara A, Kikura-Hanajiri R, Goda Y, Lesch KP, Murphy DL, Uhl GR, Sora I (2015) Methylone-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. Behav Pharmacol 26:345\u2013352","journal-title":"Behav Pharmacol"},{"key":"21_CR42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2006.11.075","volume":"559","author":"F Nagai","year":"2007","unstructured":"Nagai F, Nonaka R, Satoh Hisashi Kamimura K (2007) The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 559:132\u2013137","journal-title":"Eur J Pharmacol"},{"key":"21_CR43","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/157015911795017425","volume":"9","author":"C Sogawa","year":"2011","unstructured":"Sogawa C, Sogawa N, Ohyama K, Kikura-Hanajiri R, Goda Y, Sora I, Kitayama S (2011) Methylone and monoamine transporters: correlation with toxicity. Curr Neuropharmacol 9:58\u201362","journal-title":"Curr Neuropharmacol"},{"key":"21_CR44","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s00213-015-3944-8","volume":"232","author":"SM Aarde","year":"2015","unstructured":"Aarde SM, Creehan KM, Vandewater SA, Dickerson TJ, Taffe MA (2015) In vivo potency and efficacy of the novel cathinone alpha-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats. Psychopharmacology (Berl) 232:3045\u20133055","journal-title":"Psychopharmacology (Berl)"},{"key":"21_CR45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neuro.2014.07.004","volume":"44","author":"A Adam","year":"2014","unstructured":"Adam A, Gerecsei LI, Lepesi N, Csillag A (2014) Apoptotic effects of the \u2018designer drug\u2019 methylenedioxypyrovalerone (MDPV) on the neonatal mouse brain. Neurotoxicology 44:231\u2013236","journal-title":"Neurotoxicology"},{"key":"21_CR46","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/npp.2012.233","volume":"38","author":"WE Fantegrossi","year":"2013","unstructured":"Fantegrossi WE, Gannon BM, Zimmerman SM, Rice KC (2013) In vivo effects of abused \u2018bath salt\u2019 constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity. Neuropsychopharmacology 38:563\u2013573","journal-title":"Neuropsychopharmacology"},{"key":"21_CR47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pbb.2014.09.021","volume":"126","author":"HE King","year":"2014","unstructured":"King HE, Wetzell B, Rice KC, Riley AL (2014) 3,4-Methylenedioxypyrovalerone (MDPV)-induced conditioned taste avoidance in the F344\/N and LEW rat strains. Pharmacol Biochem Behav 126:163\u2013169","journal-title":"Pharmacol Biochem Behav"},{"key":"21_CR48","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/dev.21171","volume":"56","author":"AP Merluzzi","year":"2014","unstructured":"Merluzzi AP, Hurwitz ZE, Briscione MA, Cobuzzi JL, Wetzell B, Rice KC, Riley AL (2014) Age-dependent MDPV-induced taste aversions and thermoregulation in adolescent and adult rats. Dev Psychobiol 56:943\u2013954","journal-title":"Dev Psychobiol"},{"key":"21_CR49","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/npp.2012.204","volume":"38","author":"MH Baumann","year":"2013","unstructured":"Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, Rothman RB, Goldberg SR, Lupica CR, Sitte HH, Brandt SD, Tella SR, Cozzi NV, Schindler CW (2013) Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u2018bath salts\u2019 products. Neuropsychopharmacology 38:552\u2013562","journal-title":"Neuropsychopharmacology"},{"key":"21_CR50","doi-asserted-by":"crossref","unstructured":"Chapy H, Smirnova M, Andre P, Schlatter J, Chiadmi F, Couraud PO, Scherrmann JM, Decleves X, Cisternino S (2015) Carrier-mediated cocaine transport at the blood-brain barrier as a putative mechanism in addiction liability. Int J Neuropsychopharmacol 18","DOI":"10.1093\/ijnp\/pyu001"},{"key":"21_CR51","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1756-0500-6-220","volume":"6","author":"LD Simmler","year":"2013","unstructured":"Simmler LD, Wandeler R, Liechti ME (2013) Bupropion, methylphenidate, and 3,4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence. BMC Res Notes 6:220","journal-title":"BMC Res Notes"},{"key":"21_CR52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejphar.2007.06.022","volume":"572","author":"Y Numachi","year":"2007","unstructured":"Numachi Y, Ohara A, Yamashita M, Fukushima S, Kobayashi H, Hata H, Watanabe H, Hall FS, Lesch KP, Murphy DL, Uhl GR, Sora I (2007) Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. Eur J Pharmacol 572:120\u2013128","journal-title":"Eur J Pharmacol"},{"key":"21_CR53","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.neuroscience.2006.06.033","volume":"142","author":"RD Crean","year":"2006","unstructured":"Crean RD, Davis SA, Von Huben SN, Lay CC, Katner SN, Taffe MA (2006) Effects of (+\/-)3,4-methylenedioxymethamphetamine, (+\/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques. Neuroscience 142:515\u2013525","journal-title":"Neuroscience"},{"key":"21_CR54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-3806(97)81791-9","volume":"103","author":"GD Cappon","year":"1997","unstructured":"Cappon GD, Morford LL, Vorhees CV (1997) Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response. Brain Res Dev Brain Res 103:155\u2013162","journal-title":"Brain Res Dev Brain Res"},{"key":"21_CR55","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0031-9384(95)00136-7","volume":"58","author":"RI Dafters","year":"1995","unstructured":"Dafters RI (1995) Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing. Physiol Behav 58:877\u2013882","journal-title":"Physiol Behav"},{"key":"21_CR56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-2999(98)00758-4","volume":"363","author":"T Makisumi","year":"1998","unstructured":"Makisumi T, Yoshida K, Watanabe T, Tan N, Murakami N, Morimoto A (1998) Sympatho-adrenal involvement in methamphetamine-induced hyperthermia through skeletal muscle hypermetabolism. Eur J Pharmacol 363:107\u2013112","journal-title":"Eur J Pharmacol"},{"key":"21_CR57","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/syn.890190108","volume":"19","author":"PE Paulson","year":"1995","unstructured":"Paulson PE, Robinson TE (1995) Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse 19:56\u201365","journal-title":"Synapse"},{"key":"21_CR58","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/S0022-3565(25)39604-7","volume":"267","author":"K Yoshida","year":"1993","unstructured":"Yoshida K, Morimoto A, Makisumi T, Murakami N (1993) Cardiovascular, thermal and behavioral sensitization to methamphetamine in freely moving rats. J Pharmacol Exp Ther 267:1538\u20131543","journal-title":"J Pharmacol Exp Ther"},{"key":"21_CR59","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.drugalcdep.2012.07.003","volume":"127","author":"ML Miller","year":"2013","unstructured":"Miller ML, Creehan KM, Angrish D, Barlow DJ, Houseknecht KL, Dickerson TJ, Taffe MA (2013) Changes in ambient temperature differentially alter the thermoregulatory, cardiac and locomotor stimulant effects of 4-methylmethcathinone (mephedrone). Drug Alcohol Depend 127:248\u2013253","journal-title":"Drug Alcohol Depend"},{"key":"21_CR60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.lfs.2013.10.033","volume":"97","author":"RA Gregg","year":"2014","unstructured":"Gregg RA, Rawls SM (2014) Behavioral pharmacology of designer cathinones: a review of the preclinical literature. Life Sci 97:27\u201330","journal-title":"Life Sci"},{"key":"21_CR61","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/adb.12038","volume":"18","author":"SM Aarde","year":"2013","unstructured":"Aarde SM, Angrish D, Barlow DJ, Wright MJ Jr, Vandewater SA, Creehan KM, Houseknecht KL, Dickerson TJ, Taffe MA (2013) Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats. Addict Biol 18:786\u2013799","journal-title":"Addict Biol"},{"key":"21_CR62","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s13181-014-0446-8","volume":"11","author":"BA Froberg","year":"2015","unstructured":"Froberg BA, Levine M, Beuhler MC, Judge BS, Moore PW, Engebretsen KM, McKeown NJ, Rosenbaum CD, Young AC, Rusyniak DE (2015) Acute methylenedioxypyrovalerone toxicity. J Med Toxicol 11:185\u2013194","journal-title":"J Med Toxicol"},{"key":"21_CR63","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1096\/fj.03-0073rev","volume":"17","author":"JL Cadet","year":"2003","unstructured":"Cadet JL, Jayanthi S, Deng X (2003) Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB J 17:1775\u20131788","journal-title":"FASEB J"},{"key":"21_CR64","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1254\/jphs.92.178","volume":"92","author":"T Kita","year":"2003","unstructured":"Kita T, Wagner GC, Nakashima T (2003) Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. J Pharmacol Sci 92:178\u2013195","journal-title":"J Pharmacol Sci"},{"key":"21_CR65","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00213-006-0322-6","volume":"189","author":"MH Baumann","year":"2007","unstructured":"Baumann MH, Wang X, Rothman RB (2007) 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology (Berl) 189:407\u2013424","journal-title":"Psychopharmacology (Berl)"},{"key":"21_CR66","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF03033567","volume":"11","author":"JL Cadet","year":"2007","unstructured":"Cadet JL, Krasnova IN, Jayanthi S, Lyles J (2007) Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. Neurotox Res 11:183\u2013202","journal-title":"Neurotox Res"},{"key":"21_CR67","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12035-009-8064-1","volume":"39","author":"JP Capela","year":"2009","unstructured":"Capela JP, Carmo H, Remiao F, Bastos ML, Meisel A, Carvalho F (2009) Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol Neurobiol 39:210\u2013271","journal-title":"Mol Neurobiol"},{"key":"21_CR68","doi-asserted-by":"crossref","unstructured":"Imam SZ, el-Yazal J, Newport GD, Itzhak Y, Cadet JL, Slikker W Jr, Ali SF (2001) Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts. Ann N Y Acad Sci 939:366\u2013380","DOI":"10.1111\/j.1749-6632.2001.tb03646.x"},{"key":"21_CR69","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1369-1600.2011.00384.x","volume":"17","author":"CP Motbey","year":"2012","unstructured":"Motbey CP, Hunt GE, Bowen MT, Artiss S, McGregor IS (2012) Mephedrone (4-methylmethcathinone, \u2018meow\u2019): acute behavioural effects and distribution of Fos expression in adolescent rats. Addict Biol 17:409\u2013422","journal-title":"Addict Biol"},{"key":"21_CR70","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1124\/jpet.111.184119","volume":"339","author":"GC Hadlock","year":"2011","unstructured":"Hadlock GC, Webb KM, McFadden LM, Chu PW, Ellis JD, Allen SC, Andrenyak DM, Vieira-Brock PL, German CL, Conrad KM, Hoonakker AJ, Gibb JW, Wilkins DG, Hanson GR, Fleckenstein AE (2011) 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. J Pharmacol Exp Ther 339:530\u2013536","journal-title":"J Pharmacol Exp Ther"},{"key":"21_CR71","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/j.1476-5381.2011.01499.x","volume":"164","author":"J Kehr","year":"2011","unstructured":"Kehr J, Ichinose F, Yoshitake S, Goiny M, Sievertsson T, Nyberg F, Yoshitake T (2011) Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats. Br J Pharmacol 164:1949\u20131958","journal-title":"Br J Pharmacol"},{"key":"21_CR72","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1326-8-22","volume":"8","author":"M Toborek","year":"2013","unstructured":"Toborek M, Seelbach MJ, Rashid CS, Andras IE, Chen L, Park M, Esser KA (2013) Voluntary exercise protects against methamphetamine-induced oxidative stress in brain microvasculature and disruption of the blood-brain barrier. Mol Neurodegener 8:22","journal-title":"Mol Neurodegener"},{"key":"21_CR73","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0197-0186(97)00031-4","volume":"32","author":"JL Cadet","year":"1998","unstructured":"Cadet JL, Brannock C (1998) Free radicals and the pathobiology of brain dopamine systems. Neurochem Int 32:117\u2013131","journal-title":"Neurochem Int"},{"key":"21_CR74","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.lfs.2013.07.014","volume":"97","author":"LE Halpin","year":"2014","unstructured":"Halpin LE, Collins SA, Yamamoto BK (2014) Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine. Life Sci 97:37\u201344","journal-title":"Life Sci"},{"key":"21_CR75","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/ene.12185","volume":"21","author":"A Stepens","year":"2014","unstructured":"Stepens A, Groma V, Skuja S, Platkajis A, Aldins P, Eksteina I, Martinsone I, Bricis R, Donaghy M (2014) The outcome of the movement disorder in methcathinone abusers: clinical, MRI and manganesemia changes, and neuropathology. Eur J Neurol 21:199\u2013205","journal-title":"Eur J Neurol"},{"key":"21_CR76","first-page":"12","volume":"105","author":"OS Levin","year":"2005","unstructured":"Levin OS (2005) \u201cEphedron\u201d encephalopathy. Zh Nevrol Psikhiatr Im S S Korsakova 105:12\u201320","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"21_CR77","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/dta.313","volume":"3","author":"JP Kelly","year":"2011","unstructured":"Kelly JP (2011) Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. Drug Test Anal 3:439\u2013453","journal-title":"Drug Test Anal"},{"key":"21_CR78","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1124\/jpet.103.053975","volume":"307","author":"RB Rothman","year":"2003","unstructured":"Rothman RB, Vu N, Partilla JS, Roth BL, Hufeisen SJ, Compton-Toth BA, Birkes J, Young R, Glennon RA (2003) In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates. J Pharmacol Exp Ther 307:138\u2013145","journal-title":"J Pharmacol Exp Ther"},{"key":"21_CR79","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0014-2999(94)90669-6","volume":"264","author":"GA Gudelsky","year":"1994","unstructured":"Gudelsky GA, Yamamoto BK, Nash JF (1994) Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists. Eur J Pharmacol 264:325\u2013330","journal-title":"Eur J Pharmacol"},{"key":"21_CR80","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2015.03.004","volume":"755","author":"C Pifl","year":"2015","unstructured":"Pifl C, Reither H, Hornykiewicz O (2015) The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter. Eur J Pharmacol 755:119\u2013126","journal-title":"Eur J Pharmacol"},{"key":"21_CR81","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1111\/bph.13030","volume":"172","author":"JS Bonano","year":"2015","unstructured":"Bonano JS, Banks ML, Kolanos R, Sakloth F, Barnier ML, Glennon RA, Cozzi NV, Partilla JS, Baumann MH, Negus SS (2015) Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues. Br J Pharmacol 172:2433\u20132444","journal-title":"Br J Pharmacol"},{"key":"21_CR82","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1111\/bph.13043","volume":"172","author":"F Sakloth","year":"2015","unstructured":"Sakloth F, Kolanos R, Mosier PD, Bonano JS, Banks ML, Partilla JS, Baumann MH, Negus SS, Glennon RA (2015) Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues. Br J Pharmacol 172:2210\u20132218","journal-title":"Br J Pharmacol"},{"key":"21_CR83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2012.11.020","volume":"698","author":"MH Baumann","year":"2013","unstructured":"Baumann MH, Partilla JS, Lehner KR (2013) Psychoactive \u201cbath salts\u201d: not so soothing. Eur J Pharmacol 698:1\u20135","journal-title":"Eur J Pharmacol"},{"key":"21_CR84","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1021\/cn4001236","volume":"12","author":"R Kolanos","year":"2013","unstructured":"Kolanos R, Solis E Jr, Sakloth F, De Felice LJ, Glennon RA (2013) Deconstruction of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter. ACS Chem Neurosci 12:1524\u20131529","journal-title":"ACS Chem Neurosci"},{"key":"21_CR85","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.02.016","volume":"87","author":"JA Marusich","year":"2014","unstructured":"Marusich JA, Antonazzo KR, Wiley JL, Blough BE, Partilla JS, Baumann MH (2014) Pharmacology of novel synthetic stimulants structurally related to the \u201cbath salts\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology 87:206\u2013213","journal-title":"Neuropharmacology"},{"key":"21_CR86","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0074-7742(09)88004-5","volume":"88","author":"EA Kiyatkin","year":"2009","unstructured":"Kiyatkin EA, Sharma HS (2009) Acute methamphetamine intoxication: brain hyperthermia, blood-brain barrier, brain edema, and morphological cell abnormalities. Int Rev Neurobiol 88:65\u2013100","journal-title":"Int Rev Neurobiol"},{"key":"21_CR87","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuropharm.2014.02.015","volume":"87","author":"E O\u2019Shea","year":"2014","unstructured":"O\u2019Shea E, Urrutia A, Green AR, Colado MI (2014) Current preclinical studies on neuroinflammation and changes in blood-brain barrier integrity by MDMA and methamphetamine. Neuropharmacology 87:125\u2013134","journal-title":"Neuropharmacology"},{"key":"21_CR88","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/jcbfm.2015.59","volume":"35","author":"V Coelho-Santos","year":"2015","unstructured":"Coelho-Santos V, Leitao RA, Cardoso FL, Palmela I, Rito M, Barbosa M, Brito MA, Fontes-Ribeiro CA, Silva AP (2015) The TNF-alpha\/NF-kappaB signaling pathway has a key role in methamphetamine-induced blood-brain barrier dysfunction. J Cereb Blood Flow Metab 35:1260\u20131271","journal-title":"J Cereb Blood Flow Metab"},{"key":"21_CR89","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pnpbp.2013.04.007","volume":"45","author":"R Lopez-Arnau","year":"2013","unstructured":"Lopez-Arnau R, Martinez-Clemente J, Carbo M, Pubill D, Escubedo E, Camarasa J (2013) An integrated pharmacokinetic and pharmacodynamic study of a new drug of abuse, methylone, a synthetic cathinone sold as \u201cbath salts\u201d. Prog Neuropsychopharmacol Biol Psychiatry 45:64\u201372","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"21_CR90","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.toxlet.2012.03.009","volume":"211","author":"M Coppola","year":"2012","unstructured":"Coppola M, Mondola R (2012) Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as \u201cbath salts\u201d or \u201cplant food\u201d. Toxicol Lett 211:144\u2013149","journal-title":"Toxicol Lett"},{"key":"21_CR91","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tips.2014.11.006","volume":"36","author":"HH Sitte","year":"2015","unstructured":"Sitte HH, Freissmuth M (2015) Amphetamines, new psychoactive drugs and the monoamine transporter cycle. Trends Pharmacol Sci 36:41\u201350","journal-title":"Trends Pharmacol Sci"},{"key":"21_CR92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.12.005","volume":"147","author":"ME Reith","year":"2015","unstructured":"Reith ME, Blough BE, Hong WC, Jones KT, Schmitt KC, Baumann MH, Partilla JS, Rothman RB, Katz JL (2015) Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter. Drug Alcohol Depend 147:1\u201319","journal-title":"Drug Alcohol Depend"},{"key":"21_CR93","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.lfs.2013.10.029","volume":"97","author":"LJ De Felice","year":"2014","unstructured":"De Felice LJ, Glennon RA, Negus SS (2014) Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology. Life Sci 97:20\u201326","journal-title":"Life Sci"},{"key":"21_CR94","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00204-014-1278-7","volume":"89","author":"AM Araujo","year":"2015","unstructured":"Araujo AM, Valente MJ, Carvalho M, Dias da Silva D, Gaspar H, Carvalho F, de Lourdes Bastos M, Guedes de Pinho P (2015) Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of \u2018legal high\u2019 packages containing synthetic cathinones. Arch Toxicol 89:757\u2013771","journal-title":"Arch Toxicol"},{"key":"21_CR95","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1471-4159.2007.05155.x","volume":"105","author":"DM Thomas","year":"2008","unstructured":"Thomas DM, Francescutti-Verbeem DM, Kuhn DM (2008) The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity. J Neurochem 105:605\u2013616","journal-title":"J Neurochem"},{"key":"21_CR96","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1471-4159.1993.tb03181.x","volume":"60","author":"D Sulzer","year":"1993","unstructured":"Sulzer D, Maidment NT, Rayport S (1993) Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J Neurochem 60:527\u2013535","journal-title":"J Neurochem"},{"key":"21_CR97","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0026-895X(25)08549-9","volume":"47","author":"C Pifl","year":"1995","unstructured":"Pifl C, Drobny H, Reither H, Hornykiewicz O, Singer EA (1995) Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol Pharmacol 47:368\u2013373","journal-title":"Mol Pharmacol"}],"container-title":["Current Topics in Behavioral Neurosciences","Neuropharmacology of New Psychoactive Substances (NPS)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2016_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T15:29:57Z","timestamp":1749655797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/7854_2016_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319524429","9783319524443"],"references-count":97,"URL":"https:\/\/doi.org\/10.1007\/7854_2016_21","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"18 October 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}